Treatment with Vitamin D for those with low levels of Vitamin D reduced the risk of asthma attacks and the hospitalizations associated with it.
Highlights
- Supplementing vitamin D with the standard asthma treatment can reduce the risk of asthma attacks.
- Vitamin D boosts immune responses to respiratory viruses which trigger symptoms of asthma.
- The protective effect of vitamin D supplementation is strongest in participants with low blood vitamin D concentrations.
TOP INSIGHT
Vitamin D supplements protect against asthma attacks by boosting immune responses to respiratory viruses and reducing harmful airway inflammation.
For the study, data from 955 participants in seven randomised controlled trials, which tested the use of vitamin D supplements were collected and analyzed.
Vitamin D Supplements For Asthma
Vitamin D supplementation resulted in:
Lead researcher Professor Adrian Martineau said, "These results add to the ever growing body of evidence that vitamin D can support immune function as well as bone health. On average, three people in the UK die from asthma attacks every day. Vitamin D is safe to take and relatively inexpensive so supplementation represents a potentially cost-effective strategy to reduce this problem."
The team’s use of individual participant data also allowed them to query the extent to which different groups respond to vitamin D supplementation, in more detail than previous studies.
However, due to relatively small numbers of patients within sub-groups, the researchers caution that they did not find definitive evidence to show that effects of vitamin D supplementation differ according to baseline vitamin D status.
Professor Hywel Williams, Director of the NIHR Health Technology Assessment Programme, said: "The results of this NIHR-funded study brings together evidence from several other studies from over the world and is an important contribution to reducing uncertainties on whether Vitamin D is helpful for asthma - a common condition that impacts on many thousands of people worldwide."
Dr David Jolliffe from QMUL, first author on the paper, added: "Our results are largely based on data from adults with mild to moderate asthma: children and adults with severe asthma were relatively under-represented in the dataset, so our findings cannot necessarily be generalised to these patient groups at this stage. Further clinical trials are on-going internationally, and we hope to include data from them in a future analysis to determine whether the promise of today’s results is confirmed in an even larger and more diverse group of patients."
Reference
- Richard Beasley and Mark Weatherall. Vitamin D and asthma: a case to answer, Lancet Respiratory Medicinehttp://dx.doi.org/10.1016/S2213-2600(17)30346-6.
Source-Medindia
MEDINDIA





Email










